Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Dina Lansey"'
Autor:
Susan Eggly, Nicole Senft, Seongho Kim, Elisabeth I. Heath, Hyejeong Jang, Tanina F. Moore, Fatmeh Baidoun, Mark A. Manning, Louis A. Penner, Terrance L. Albrecht, Michael A. Carducci, Dina Lansey, Lauren M. Hamel
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8604-8613 (2023)
Abstract Background Cancer clinical trial participation is low and inequitable. Partnering Around Cancer Clinical Trials (PACCT) addressed systemic and interpersonal barriers through an observational study of eligibility and an intervention to improv
Externí odkaz:
https://doaj.org/article/a916f874cc714ab398ae83b5f5cb1817
Autor:
Ahmed Hassoon, Yasmin Baig, Daniel Q. Naiman, David D. Celentano, Dina Lansey, Vered Stearns, Josef Coresh, Jennifer Schrack, Seth S. Martin, Hsin-Chieh Yeh, Hadas Zeilberger, Lawrence J. Appel
Publikováno v:
npj Digital Medicine, Vol 4, Iss 1, Pp 1-6 (2021)
Abstract Physical activity (PA) has numerous health benefits. Personalized coaching may increase adherence to PA recommendations, but it is challenging to deliver personalized coaching in a scalable manner. The objective of our study was to determine
Externí odkaz:
https://doaj.org/article/edb5c6ab91524334a6602cd38189f8d9
Autor:
Susan Eggly, Nicole Senft, Seongho Kim, Elisabeth I. Heath, Hyejeong Jang, Tanina F. Moore, Fatmeh Baidoun, Mark A. Manning, Louis A. Penner, Terrance L. Albrecht, Michael A. Carducci, Dina Lansey, Lauren M. Hamel
Publikováno v:
Cancer Medicine. 12:8604-8613
Cancer clinical trial participation is low and inequitable. Partnering Around Cancer Clinical Trials (PACCT) addressed systemic and interpersonal barriers through an observational study of eligibility and an intervention to improve patient-physician
Autor:
Susan Eggly, Lauren M. Hamel, Elisabeth Heath, Mark A. Manning, Terrance L. Albrecht, Ellen Barton, Mark Wojda, Tanina Foster, Michael Carducci, Dina Lansey, Ting Wang, Rehab Abdallah, Narineh Abrahamian, Seongho Kim, Nicole Senft, Louis A. Penner
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial. Under-enrollment is an even greater problem among min
Externí odkaz:
https://doaj.org/article/bf62ad5127d74673ac6b73f1b89d242f
Autor:
Nicole Senft, Seongho Kim, Hyejeong Jang, Mark Manning, Tanina Foster-Moore, Fatmeh Baidoun, Michael Carducci, Dina Lansey, Elisabeth Heath, Susan Eggly
Publikováno v:
Patient Education and Counseling. 109:50-51
Autor:
Lauren M. Hamel, Nicole Senft, Seongho Kim, Hyejeong Jang, Mark A. Manning, Tanina Foster, Fatmeh Baidoun, Michael Anthony Carducci, Dina Lansey, Elisabeth I. Heath, Susan Eggly
Publikováno v:
Journal of Clinical Oncology. 40:e24137-e24137
101 Background: Cancer clinical trial enrollment rates are low, with Black individuals especially underrepresented. We tested Partnering Around Cancer Clinical Trials (PACCT), a multi-level intervention designed to improve patient-physician communica
Autor:
Edgar R. Miller, Dina Lansey, Nisa M. Maruthur, Jeanne Charleston, Nae Yuh Wang, Karen White, Hsin Chieh Yeh, Eva Tseng, Michael A. Carducci, Lawrence J. Appel, Gerald J. Jerome, Ahmed Hassoon, Arlene Dalcin, Noel T. Mueller, Nowella Durkin, Norma Kanarek, Stephen P. Juraschek
Publikováno v:
J Clin Endocrinol Metab
Context Higher levels of insulin-like growth factor-1 (IGF-1) are associated with increased risk of cancers and higher mortality. Therapies that reduce IGF-1 have considerable appeal as means to prevent recurrence. Design Randomized, 3-parallel-arm c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa7f68a3674e881a67221bbf4ded8fb0
https://europepmc.org/articles/PMC8475239/
https://europepmc.org/articles/PMC8475239/
Autor:
Dina Lansey, Elisabeth I. Heath, Susan Eggly, Michael A. Carducci, Louis A. Penner, Terrance L. Albrecht, Mark Manning, Lauren M. Hamel, Tanina Foster Moore, Nicole Senft
PurposeClinical trials are critical to advancing cancer treatments, yet their impact is hindered by low accrual rates, especially among minorities. One barrier is the quality of physician communication during clinical interactions in which trials are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7779c11366f6dae070eb2062991f7480
https://doi.org/10.21203/rs.3.rs-281271/v1
https://doi.org/10.21203/rs.3.rs-281271/v1
Autor:
Mark Manning, Lauren M. Hamel, Tanina Foster Moore, Seongho Kim, Mark Wojda, Alice Jordan, Terrance L. Albrecht, Susan Eggly, Michael A. Carducci, Louis A. Penner, Nicole Senft, Dina Lansey, Elisabeth I. Heath
Publikováno v:
JAMA Oncol
IMPORTANCE: Black individuals are underrepresented in cancer clinical trials. OBJECTIVE: To examine whether Black and White men with prostate cancer differ in their willingness to discuss clinical trials with their physicians and, if so, whether pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775417428ceb0e3debaf1eb467a39d96
https://europepmc.org/articles/PMC7499244/
https://europepmc.org/articles/PMC7499244/
Autor:
Jennifer A. Schrack, Vered Stearns, Dina Lansey, David D. Celentano, Yasmin Baig, Lawrence J. Appel, Ahmed Hassoon, Seth S. Martin, Daniel Naimann
Publikováno v:
Circulation. 141
Importance: Physical Activity (PA) has numerous health benefits to cancer survivors, but motivation remains problematic. Coaching may increase PA and improve survivorship outcomes, but it is challenging to deliver personalized coaching at scale Objec